Technology

  • DNA Encoded Library (DEL) is an innovative drug discovery technology rapidly gaining wide spread interest in the pharmaceutical industry in recent years. It combines the power of molecular biology, combinatorial chemistry, high throughput sequencing and advanced informatics to create vast number of novel molecules for hit identification and lead generation. HitGen has been building a large collection of novel, diverse and drug-like DELs as its primary drug discovery platform.


  • Read More

Pipeline

  • Currently HitGen has more than 20 internal projects in research, with 1 in Phase I, 2 in PCC generation and 2 in lead generation,mainly focused on oncology, CVD, inflammation/ respiratory, metabolism and ophthalmology.
  • Read More
Target Project Progress Therapeutic Area
Target: Deacetylase Target: Phosphatase Target: Dehydrogenase Target: Dioxygenase Target: Kinase Target: Protease Target: Lipase Target: Methyltransferase Target: GPCR Target:  Protein Protein Interaction Project progress: Target Preparation Project progress: Target Screening Project progress: Hit Validation Project progress: Hit2Lead Optimization Project progress: Lead Optimization Project progress: PCC generation Therapeutic Area: Ophthalmology Therapeutic Area: Metabolism Therapeutic Area: Inflammation/Respiratory Therapeutic Area: Cardiovascular Therapeutic Area: Oncology
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 1
  • 2
  • 3
  • 4
  • 5

Partnering

  • 01

    DNA Encoded Library Screening
    HitGen will screen its most up to date proprietary DELs (hundreds of billions of novel small molecules and macrocycles) against targets provided by the partners.
  • 02

    Custom DNA Encoded Library Synthesis
    HitGen will be responsible for the design and synthsis of DNA encoded library base on partner's specification. 
  • 03

    Innovative Drug Project Collaboration

    HitGen initiates a number of innovative drug discovery projects. These projects can be the subject of collaboration, which cover the areas of oncology, CVD, inflammation/ respiratory, metabolism and ophthalmology.


Read More
  • Careers

  • Here, we build future together! 

    Here, we create innovative medicine for patients!

  • Read More
-->
福建时时彩开奖列表 北京pk104码 保加利亚与英格兰足球比分预测 广西快3和值推荐码 陕西快乐十分*规则 极速11选5是哪办的 澳洲幸运10开奖结果 热点股票推荐 贵州快三开奖奖金查询 11选5任2每期必中技巧 福彩排列7开奖结果 pk10官方 足彩比分推荐实弹 好友会昌麻将最新版 北京快三开奖结果询今天 江西十一选五开走势 29选七1000期走势图